Navigation Links
Organovo Reports Q3 2012 Financial Results, Provides Business Update
Date:11/16/2012

SAN DIEGO, Nov. 16, 2012 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo") a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported on its financial results for the three and nine month period ended September 30, 2012.

Third Quarter Corporate Highlights

  • National Institutes of Health three dimensional liver research grant revenue
  • Receipt of two issued patents, including Company's first assigned patent
  • Move to new, larger research and headquarters facility
  • Appointment of additional independent director to serve as Audit Committee Chairman
  • Third quarter 2012 revenues increased by $237,300 or approximately 102% over the same period in 2011, commensurate with the Company's continued delivery against collaborative research agreements and the initiation of research activities within the scope of a grant from the National Institutes of Health ("NIH").  Collaborative research agreement revenues contributed $141,800 or 60% of the revenue increase while grant revenues contributed $95,500.

    Cash receipts related to the reported revenues partially offset the Company's operating expenses and strengthened our balance sheet.  During the quarter the balance sheet was additionally strengthened through the receipt of approximately $1.7 million in capital from warrant and stock option exercises.  The Company had approximately $7.7 million cash on hand at the end of the quarter.  While the Company reported net earnings of approximately $38.5 million for the quarter, investors should note those earnings were primarily the result of a non-cash adjustment resulting from the change in fair value of our warrant liabilities.  The warrant liability is volatile in nature and is driven primarily by changes in the price of our Common stock, absent material changes in the number of warrants outstanding.  Investors should anticipat
    '/>"/>

    SOURCE Organovo Holdings, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
    2. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
    3. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
    4. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
    5. Organovo Announces Relocation and Commencement of Operations at Larger Facility
    6. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
    7. Organovo To Present At Lazard Healthcare Conference
    8. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    10. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    11. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... BOSTON , Jan. 22, 2015  Transwestern | RBJ today ... feet of office space for Shire a leading biopharmaceutical company, ... . Transwestern | RBJ,s Robert Richards , president, and ... the lease for the entire five-floor building at 95 Hayden ...
    (Date:1/22/2015)... Johnston, RI (PRWEB) January 22, 2015 ... State , The growing team of brand-neutral, independent consultants, ... CIO Philip Rogers explained that over the years, his ... including , Moroso, Town of Plainfield, as well as ...
    (Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a ... check the legal requirements around using controlled substances in ... , As their international operations expand and become increasingly ... built as a result of the first phase of ...
    (Date:1/22/2015)... Medical Systems (NYSE: VAR ), world leader in ... to sustainability with inclusion on a prestigious list of the ... equipment company among the Corporate Knights Global 100 Most Sustainable ... Davos, Switzerland . "We ...
    Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2
    ... CHAPEL, Florida, March 20 NexGen,Biofuels Ltd. (OTC:NXGNF) ... its ordinary shares have been approved for quotation ... NexGen is a development stage company that is ... plants and blending assets in,the United States., ...
    ... increasing physician acceptance of electrophysiology ablation ... fibrillation, according to ... According to Millennium,Research Group,s Global Markets for Atrial Fibrillation ... were,performed for the treatment of AF in the US ...
    ... LUMEDX Corporation, a leading,provider of fully integrated ... version of its real-time patient and resource,scheduler ... physicians, staff, rooms with drag and drop ... and,substantial ROI., A free CardioSchedule Information ...
    Cached Biology Technology:Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years 2LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems 2
    (Date:1/22/2015)... CHARLOTTE, N.C. , Jan. 22, 2015 Infinisource has ... introduction of the G2 model. The G2 sets a higher ... company,s iSolved human capital management solution. With plug-and-play installation, touch ... G2 time clock provides a robust time collection solution for ...
    (Date:12/22/2014)...  The 2014 Holiday Season may be the brightest ever ... that the long anticipated floodgates for consumer biometrics may ... smart phones, tablets, and wearable mobile devices that incorporate ... users with nearly 4.8 billion biometric devices by 2020.   ...
    (Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ...
    Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
    ... Power ... Consumption, TUSTIN, ... high-performance module designed for connecting,devices that require low power consumption to ... applications that need,WLAN connectivity with minimal power usage, such as battery-operated,portable ...
    ... WASHINGTON -- A new NASA-led study shows human-caused climate ... of Earth,s natural systems, including permafrost thawing, plants blooming ... Africa. Cynthia Rosenzweig of NASA,s Goddard Institute ... 10 other institutions have linked physical and biological impacts ...
    ... May 13, 2008.-Unlike most scientific and technological advances, which ... often finds itself the center of public debate and ... by many of its applications. , In this ... (the first was in 2003), the sample has been ...
    Cached Biology News:New Silex SX-560 Enables Enterprise 802.11 Wireless Connectivity for Battery Operated Devices 2NASA study links Earth impacts to human-caused climate change 2BBVA Foundation international study on attitudes to stem cell research 2BBVA Foundation international study on attitudes to stem cell research 3BBVA Foundation international study on attitudes to stem cell research 4BBVA Foundation international study on attitudes to stem cell research 5BBVA Foundation international study on attitudes to stem cell research 6
    ... the world of discovery races ever faster, you ... the fast track. So our constant focus is ... your research. Thats why our Biomek 3000 Laboratory ... as advanced as it is flexible. By integrating ...
    ... Zymeds MaxArray Rabbit Tissue Arrays contain 60 rabbit ... Each package contains 4 unstained slides and 1 ... reference. Each slide contains 15 different tissues from ... tissue samples per slide. Each tissue sample (or ...
    ... offers custom peptide synthesis with a wide variety ... fit your research needs. Purity: ... 2mg-1g Sequence Length: Up ... Fluorescein, N-acetylation, C-amidation, phosphorylation, D-amino acids, MAPs, KLH/BSA ...
    ... sequence: H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH 2 ... corresponding peptide and ... 5 I-labelled peptide, please ... and ([ 1 ...
    Biology Products: